Skip to main content

Published locations for Tofacitinib for RA misses the mark in safety study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tofacitinib for RA misses the mark in safety study

User login

  • Reset your password
  • /content/tofacitinib-ra-misses-mark-safety-study
  • /clinicianreviews/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /familypracticenews/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /internalmedicinenews/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /rheumatologynews/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /cardiology/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /rheumatology/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /internalmedicine/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /familymedicine/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety-study
  • /psoriatic-arthritis-icymi/article/235281/rheumatoid-arthritis/tofacitinib-ra-misses-mark-safety